These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25709771)

  • 1. Intravitreal bevacizumab injection alone or combined with triamcinolone versus macular photocoagulation in bilateral diabetic macular edema; application of bivariate generalized linear mixed model with asymmetric random effects in a subgroup of a clinical trial.
    Yaseri M; Zeraati H; Mohammad K; Soheilian M; Ramezani A; Eslani M; Peyman GA
    J Ophthalmic Vis Res; 2014; 9(4):453-60. PubMed ID: 25709771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M; Ramezani A; Obudi A; Bijanzadeh B; Salehipour M; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Peyman GA
    Ophthalmology; 2009 Jun; 116(6):1142-50. PubMed ID: 19376585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravitreal bevacizumab (avastin) injection alone or combined with triamcinolone versus macular photocoagulation as primary treatment of diabetic macular edema.
    Soheilian M; Ramezani A; Bijanzadeh B; Yaseri M; Ahmadieh H; Dehghan MH; Azarmina M; Moradian S; Tabatabaei H; Peyman GA
    Retina; 2007; 27(9):1187-95. PubMed ID: 18046223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-year results of a randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus laser in diabetic macular edema.
    Soheilian M; Garfami KH; Ramezani A; Yaseri M; Peyman GA
    Retina; 2012 Feb; 32(2):314-21. PubMed ID: 22234244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal bevacizumab versus combined bevacizumab-triamcinolone versus macular laser photocoagulation in diabetic macular edema.
    Faghihi H; Roohipoor R; Mohammadi SF; Hojat-Jalali K; Mirshahi A; Lashay A; Piri N; Faghihi Sh
    Eur J Ophthalmol; 2008; 18(6):941-8. PubMed ID: 18988166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravitreal bevacizumab alone or combined with 1 mg triamcinolone in diabetic macular edema: a randomized clinical trial.
    Riazi-Esfahani M; Riazi-Esfahani H; Ahmadraji A; Karkhaneh R; Mahmoudi A; Roohipoor R; Ghasemi F; Yaseri M
    Int Ophthalmol; 2018 Apr; 38(2):585-598. PubMed ID: 28349504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of intravitreal bevacizumab alone or combined with triamcinolone versus triamcinolone in diabetic macular edema: a randomized clinical trial.
    Lim JW; Lee HK; Shin MC
    Ophthalmologica; 2012; 227(2):100-6. PubMed ID: 21997197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal Bevacizumab with or without Triamcinolone for Refractory Diabetic Macular Edema: Long-term Results of a Clinical Trial.
    Shoeibi N; Ahmadieh H; Entezari M; Yaseri M
    J Ophthalmic Vis Res; 2013 Apr; 8(2):99-106. PubMed ID: 23943683
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial macular thickness and response to treatment in diabetic macular edema.
    Soheilian M; Ramezani A; Yaseri M; Mirdehghan SA; Obudi A; Bijanzadeh B
    Retina; 2011 Sep; 31(8):1564-73. PubMed ID: 21451442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal bevacizumab alone or combined with triamcinolone acetonide as the primary treatment for diabetic macular edema.
    Marey HM; Ellakwa AF
    Clin Ophthalmol; 2011; 5():1011-6. PubMed ID: 21845026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal bevacizumab versus intravitreal triamcinolone for diabetic macular edema-Systematic review, meta-analysis and meta-regression.
    Abdel-Maboud M; Menshawy E; Bahbah EI; Outani O; Menshawy A
    PLoS One; 2021; 16(1):e0245010. PubMed ID: 33434220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of intravitreal bevacizumab with or without triamcinolone acetonide for treatment of diabetic macular edema.
    Jin E; Luo L; Bai Y; Zhao M
    Ann Pharmacother; 2015 Apr; 49(4):387-97. PubMed ID: 25622852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using skew-symmetric mixed models for investigating the effect of different diabetic macular edema treatments by analyzing central macular thickness and visual acuity responses.
    Mansourian M; Kazemnejad A; Kazemi I; Zayeri F; Soheilian M
    J Res Med Sci; 2011 Oct; 16(10):1319-25. PubMed ID: 22973326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal bevacizumab and/or macular photocoagulation as a primary treatment for diffuse diabetic macular edema.
    Solaiman KA; Diab MM; Abo-Elenin M
    Retina; 2010; 30(10):1638-45. PubMed ID: 20838357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravitreal triamcinolone versus intravitreal bevacizumab for diabetic macular edema: a meta-analysis.
    Zhang XL; Chen J; Zhang RJ; Wang WJ; Zhou Q; Qin XY
    Int J Ophthalmol; 2013; 6(4):546-52. PubMed ID: 23991395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab with or without triamcinolone acetonide for diabetic macular edema: a meta-analysis of randomized controlled trials.
    Liu X; Zhou X; Wang Z; Li T; Jiang B
    Chin Med J (Engl); 2014; 127(19):3471-6. PubMed ID: 25269916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S; Vojniković B
    Coll Antropol; 2010 Apr; 34 Suppl 2():99-103. PubMed ID: 21305729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Bevacizumab with or without triamcinolone for refractory diabetic macular oedema.
    Synek S; Veselý P
    Coll Antropol; 2011 Sep; 35(3):841-5. PubMed ID: 22053565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab versus combined intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration: six-month results of a randomized clinical trial.
    Ahmadieh H; Taei R; Riazi-Esfahani M; Piri N; Homayouni M; Daftarian N; Yaseri M
    Retina; 2011 Oct; 31(9):1819-26. PubMed ID: 21555967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.